| dc.contributor.author | Arizcorreta, Ana | |
| dc.contributor.author | Márquez Coello, María de las Mercedes | |
| dc.contributor.author | Fernández-Gutiérrez del Álamo, Clotilde | |
| dc.contributor.author | Guzman, Eugenio Perez | |
| dc.contributor.author | Brun Romero, Francisco Manuel | |
| dc.contributor.author | Rodríguez Iglesias, Manuel Antonio | |
| dc.contributor.author | Girón González, José Antonio | |
| dc.contributor.other | Biomedicina, Biotecnología y Salud Pública | es_ES |
| dc.date.accessioned | 2025-01-28T16:49:09Z | |
| dc.date.available | 2025-01-28T16:49:09Z | |
| dc.date.issued | 2006-09-29 | |
| dc.identifier.issn | 0009-9104 | |
| dc.identifier.uri | http://hdl.handle.net/10498/34946 | |
| dc.description.abstract | Interferon (IFN)-α induced CD4+ T lymphopenia is a toxic effect of the treatment of chronic hepatitis C virus (HCV) in human immunodeficiency virus (HIV)-co-infected patients. To increase the knowledge about this secondary effect, we performed an analysis of the evolution of the T cell receptor excision circles (TRECs), CD4+ and CD8+ T cells and of their CD45RO+ and CD45RA+ subpopulations during the treatment of chronic hepatitis HCV with peginterferon alpha (pegIFN-α) + ribavirin. Twenty HCV/HIV-co-infected patients, with undetectable HIV load after highly active antiretroviral therapy (HAART), were treated with pegIFN-α + ribavirin. TRECs were determined using real-time polymerase chain reaction. CD4+ and CD8+ T cells and their CD45RO+ and CD45RA+ subpopulations were analysed by two-colour flow cytometry. Median baseline CD4+ and CD8+ T cells were 592 mm3 and 874 mm3, respectively. Median baseline CD45RO+ subpopulation was 48% for CD4+ T and 57% for CD8+ T lymphocytes. A progressive decrease in both T cell populations, as well as of their CD45RO+ and CD45RA+ subpopulations, was detected, with a difference between the baseline and nadir levels approaching 50%. The evolution of T cell populations and TRECs was independent of the response to the treatment. T lymphocytes and their subpopulations returned to baseline levels at 24 weeks after the end of treatment, with the exception of the T CD4+ CD45RA+ subpopulation. The ratio of CD4+ CD45RO+/CD4+ CD45RA+ increased from 0·89 (baseline) to 1·44 (24 weeks after the end of the therapy). TRECs/ml did not return to the basal values. In conclusion, a significant reduction of CD4+ and CD8+ T cells, and of their CD45RA+ and CD45RO+ subpopulations, in HIV/HCV co-infected patients treated with pegIFN-α was observed. Both subpopulations increased after the suppression of treatment, but the CD4+ CD45RA subpopulation did not reach the basal levels as a consequence, at least in part, of a decrease in thymic production. | es_ES |
| dc.format | application/pdf | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Oxford Academic | es_ES |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.source | Clinical and Experimental Immunology, Vol. 146, Núm. 2, 2006, pp. 270-27 | es_ES |
| dc.title | T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+ subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy | es_ES |
| dc.type | journal article | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.identifier.doi | 10.1111/J.1365-2249.2006.03220.X | |
| dc.type.hasVersion | VoR | es_ES |